SMI 12’026 0.4%  SPI 15’577 0.5%  Dow 34’687 -0.4%  DAX 15’652 0.2%  Euro 1.0888 0.2%  EStoxx50 4’170 0.6%  Gold 1’755 -2.2%  Bitcoin 44’462 0.4%  Dollar 0.9256 0.6%  Öl 75.4 -0.2% 

Centene Aktie 1313733 / US15135B1017

56.57
CHF
0.06
CHF
0.10%
17:29:57
BRX

Aktionärsstruktur

Inhaber in %
Freefloat 97.95
The Vanguard Group, Inc. 10.62
Vanguard Group, Inc. (Subfiler) 10.18
Capital Research & Management Co. (World Investors) 7.68
T. Rowe Price Associates, Inc. (Investment Management) 5.06
Fidelity Management & Research Co. LLC 4.54
State Street Corp. 4.03
Capital Research & Management Co. (International Investors) 3.44
Wellington Management Co. LLP 3.26
American Funds Fundamental Investors 3.22
Vanguard Total Stock Market Index Fund 2.82
American Funds Growth Fund of America 2.53
BlackRock Fund Advisors 2.23
Vanguard Mid Cap Index Fund 2.23
BlackRock Institutional Trust Co. NA 2.11

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2016 2017 2018 2019 2020
Personal am Ende des Jahres 30’500 33’700 47’300 56’600 71’300
Umsatz pro Mitarbeiter in Mio. EUR 1.33 1.44 1.27 1.32 1.56

Bilanz (in Mio. EUR) - Aktiva

2016 2017 2018 2019 2020
Summe Umlaufvermögen 8’365 8’703 11’998 20’323 23’393
Summe Anlagevermögen 10’550 11’549 17’603 27’060 44’090
Summe Aktiva 20’197 21’855 30’901 40’994 69’843

Bilanz (in Mio. EUR) - Passiva

2016 2017 2018 2019 2020
Gesamtverschuldung/ -verbindlichkeiten 4’655 4’699 6’686 14’509 18’317
Summe Fremdkapital 14’143 14’979 19’878 28’302 43’881
Summe Eigenkapital 6’054 6’876 11’023 12’692 25’962
Summe Passiva 20’197 21’855 30’901 40’994 69’843

Adresse

7700 Forsyth Boulevard, 63105 St. Louis
Telefon +1 (314) 725-4477
URL http://www.centene.com

Management

Anand Shukla
SVP-Commercial Solutions
Andrew Lynn Asher
Chief Financial Officer & Executive Vice President
Brent Davis Layton
President & Chief Operating Officer
Chan Arvan
Regional Vice President & Corporate Operations
Christopher Koster
Secretary, Senior Vice President & General Counsel
Claudio Abreu
Executive Vice President
Colin Toney
Executive Vice President-Mergers & Acquisitions
David L. Steward
Independent Director
David P. Thomas
Executive Vice President-Markets
Frederick H. Eppinger
Independent Director
H. James Dallas
Independent Director
H. Robert Sanders
Executive Vice President-Global Human Resources
Jeffrey A. Schwaneke
Executive Vice President-HealthCare Enterprises
Jennifer Gilligan
Senior Vice President-Investor Relations
Jessica L. Blume
Independent Director
John R. Roberts
Independent Director
Katie Casso
Vice President & Controller
Ken Yamaguchi
Chief Medical Officer & Executive Vice President
Kevin J. Counihan
Senior Vice President-Products
Lori J. Robinson
Independent Director
Mark J. Brooks
Chief Information Officer & Executive VP
Mary V. Mason
Chief Medial Officer & Senior Vice President
Matthew Snyder
SVP-Internal Audit, Compliance & Risk Management
Michael F. Neidorff
Chairman & Chief Executive Officer
Orlando Lozano Ayala
Independent Director
Rich Fisher
Senior VP & Chief Executive Officer-Medicare
Richard A. Gephardt
Independent Director
Robert K. Ditmore
Lead Independent Director
Sarah London
Vice Chairman
Shannon Bagley
Chief Administrative Officer & Executive VP
Suzy DePrizio
Chief Marketing Officer & Senior Vice President
Tommy George Thompson
Independent Director
William L. Trubeck
Independent Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen